Independent Medical Biology Unit, Faculty of Pharmacy, Medical University of Lublin, 20-093 Lublin, Poland.
Human Anatomy Department, Faculty of Medicine, Medical University of Lublin, 20-090 Lublin, Poland.
Int J Mol Sci. 2022 May 16;23(10):5572. doi: 10.3390/ijms23105572.
Cancer is the second most common cause of death worldwide after cardiovascular diseases. The development of molecular and biochemical techniques has expanded the knowledge of changes occurring in specific metabolic pathways of cancer cells. Increased aerobic glycolysis, the promotion of anaplerotic responses, and especially the dependence of cells on glutamine and fatty acid metabolism have become subjects of study. Despite many cancer treatment strategies, many patients with neoplastic diseases cannot be completely cured due to the development of resistance in cancer cells to currently used therapeutic approaches. It is now becoming a priority to develop new treatment strategies that are highly effective and have few side effects. In this review, we present the current knowledge of the enzymes involved in the different steps of glycolysis, the Krebs cycle, and the pentose phosphate pathway, and possible targeted therapies. The review also focuses on presenting the differences between cancer cells and normal cells in terms of metabolic phenotype. Knowledge of cancer cell metabolism is constantly evolving, and further research is needed to develop new strategies for anti-cancer therapies.
癌症是全球范围内仅次于心血管疾病的第二大死亡原因。分子和生化技术的发展扩展了对癌细胞特定代谢途径中发生变化的认识。有氧糖酵解增加、碳固定反应的促进,特别是细胞对谷氨酰胺和脂肪酸代谢的依赖,已成为研究的主题。尽管有许多癌症治疗策略,但由于肿瘤细胞对目前使用的治疗方法产生了耐药性,许多患有肿瘤疾病的患者无法被完全治愈。因此,开发高效且副作用小的新治疗策略已成为当务之急。在这篇综述中,我们介绍了参与糖酵解、三羧酸循环和磷酸戊糖途径不同步骤的酶以及可能的靶向治疗方法的最新知识。本文还重点介绍了癌细胞和正常细胞在代谢表型方面的差异。对癌细胞代谢的认识在不断发展,需要进一步研究以开发新的抗癌治疗策略。